Mesothelioma
Lilly, patients hope drug for asbestos-related cancer gains OK
Published in Medical Letter on the CDC and FDA, June 23rd, 2002
If approved, the drug, known as Alimta, would become the first medicine sanctioned by the U.S. Food and Drug Administration (FDA) specifically to treat mesothelioma. The deadly tumors of the lungs or stomach are resistant to treatment and the cancer is nearly always fatal.
Alimta could hold promise for thousands of workers in the construction and shipbuilding trades worldwide who handled asbestos and could contract mesothelioma. Lilly is seeking a priority review by the FDA, meaning the regulator would review the drug...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Psychology
U.S. Preventive Services task force finds sufficient evidence to recommend screening adults for depression - Smallpox
That scar on your arm won't help if the man next to you is infected - Anthrax
Researchers announce experimental antidote - Drug Development
Study: Few new drugs in last decade were improvement - Environmental Contaminants
World Trade Center site workers not exposed to hazardous asbestos, study says - Food-borne Illness
Officials trace origin of salmonella outbreak - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
